Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers
A. Takeda et al., Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers, ONCOL REP, 7(2), 2000, pp. 333-338
Vascular endothelial growth factor (VEGF) is known as a potent inducer of a
ngiogenesis in various human cancers. Serum VEGF concentrations of colorect
al cancer patients was assessed for their clinical significance as a tumor
marker. Serum samples were obtained at admission from 24 healthy volunteers
and 111 patients with colorectal cancer. Preoperative serum VEGF concentra
tions, which are significantly higher than those of healthy controls, refle
ct clinical stage progression, depth of invasion, liver metastasis, lymph n
ode metastasis and lymphatic invasion. Consequently, detection of VEGF coul
d serve as a clinically useful marker for colorectal cancer progression and
metastasis independent of other markers.